Literature DB >> 29549607

Elevated serum neopterin levels in children with functional constipation: association with systemic proinflammatory cytokines.

Ceren Cıralı1, Emel Ulusoy1, Tuncay Kume2, Nur Arslan3.   

Abstract

BACKGROUND: Functional constipation is a clinical problem with an incompletely understood etiology. Functional bowel diseases have been shown to be related to inflammation in many studies in adults. In this study, we aimed to evaluate leukocytes, C-reactive protein, proinflammatory and anti-inflammatory cytokines, and neopterin levels in children with functional constipation.
METHODS: Seventy-six children with constipation and 71 healthy controls (mean age 7.12 ± 3.46 years and 7.32 ± 4.33 years, respectively, P = 0.991) were included in the study. Leukocytes, C-reactive protein, interleukin (IL)-1β, IL-6, IL-10, IL-12, tumor necrosis factor-alpha (TNF-α) and neopterin levels were assessed in patients and healthy controls. Parameters were measured in the serum using enzyme-linked immunosorbent assay methods.
RESULTS: Mean IL-6 (20.31 ± 12.05 vs. 16.2 ± 10.25 pg/mL, respectively, P = 0.003), IL-12 (181.42 ± 133.45 vs. 135.6 ± 83.67 pg/mL, respectively, P = 0.018) and neopterin levels (2.08 ± 1.12 vs. 1.52 ± 1.02 pg/mL, respectively, P = 0.001) were significantly higher in constipated children than healthy controls. Leukocyte and thrombocyte counts, C-reactive protein, and IL-1β, IL-10 and TNF-α levels did not show any difference between the two groups.
CONCLUSIONS: In this study, IL-6, IL-12 and neopterin levels of constipated patients were found to be higher than those of controls. These results indicate the presence of subclinical inflammation in children with functional constipation.

Entities:  

Keywords:  Children; Constipation; Cytokine; Inflammation; Neopterin

Mesh:

Substances:

Year:  2018        PMID: 29549607     DOI: 10.1007/s12519-018-0144-8

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  47 in total

Review 1.  Neopterin as a marker for immune system activation.

Authors:  C Murr; B Widner; B Wirleitner; D Fuchs
Journal:  Curr Drug Metab       Date:  2002-04       Impact factor: 3.731

2.  Neopterin Release and Tryptophan Degradation in Patients with Uveitis.

Authors:  Saziye Sezin Palabiyik; Sadullah Keles; Gözde Girgin; Eren Arpali-Tanas; Elif Topdagi; Terken Baydar
Journal:  Curr Eye Res       Date:  2016-05-09       Impact factor: 2.424

3.  Inflammatory bowel disease, cancer and medication: Cancer risk in the Dutch population-based IBDSL cohort.

Authors:  Tim R A van den Heuvel; Dion S J Wintjens; Steven F G Jeuring; Maartje H H Wassink; Marielle J L Romberg-Camps; Liekele E Oostenbrug; Silvia Sanduleanu; Wim H Hameeteman; Maurice P Zeegers; Ad A Masclee; Daisy M Jonkers; Marie J Pierik
Journal:  Int J Cancer       Date:  2016-05-31       Impact factor: 7.396

4.  Serum immune biomarkers in irritable bowel syndrome.

Authors:  Seyedmehdi Seyedmirzaee; Mohammad Mahdi Hayatbakhsh; Bizhan Ahmadi; Nadieh Baniasadi; Afshin Mohammad Bagheri Rafsanjani; Amin Reza Nikpoor; Mojgan Mohammadi
Journal:  Clin Res Hepatol Gastroenterol       Date:  2016-02-02       Impact factor: 2.947

5.  Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators.

Authors:  T Piche; G Barbara; P Aubert; S Bruley des Varannes; R Dainese; J L Nano; C Cremon; V Stanghellini; R De Giorgio; J P Galmiche; M Neunlist
Journal:  Gut       Date:  2008-09-29       Impact factor: 23.059

6.  Intestinal inflammation measured by fecal neopterin in Gambian children with enteropathy: association with growth failure, Giardia lamblia, and intestinal permeability.

Authors:  David I Campbell; Graham McPhail; Peter G Lunn; Marinos Elia; Donald J Jeffries
Journal:  J Pediatr Gastroenterol Nutr       Date:  2004-08       Impact factor: 2.839

7.  Evaluation of proinflammatory cytokine and neopterin levels in women with papillary thyroid carcinoma.

Authors:  Kemal Beksac; Cigdem Sonmez; Bahadir Cetin; Gorkem Kismali; Tevhide Sel; Yildirim Tuncer; Funda Kosova
Journal:  Int J Biol Markers       Date:  2016-12-23       Impact factor: 2.659

8.  Structural changes in the gut microbiome of constipated patients.

Authors:  Lixin Zhu; Wensheng Liu; Razan Alkhouri; Robert D Baker; Jonathan E Bard; Eamonn M Quigley; Susan S Baker
Journal:  Physiol Genomics       Date:  2014-07-29       Impact factor: 3.107

9.  Tryptophan degradation in irritable bowel syndrome: evidence of indoleamine 2,3-dioxygenase activation in a male cohort.

Authors:  Gerard Clarke; Peter Fitzgerald; John F Cryan; Eugene M Cassidy; Eamonn M Quigley; Timothy G Dinan
Journal:  BMC Gastroenterol       Date:  2009-01-20       Impact factor: 3.067

10.  Chemotactic chemokines are important in the pathogenesis of irritable bowel syndrome.

Authors:  Charles Darkoh; Latoya Comer; Getie Zewdie; Stephen Harold; Ned Snyder; Herbert L Dupont
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

View more
  2 in total

Review 1.  Diet supporting therapy for inflammatory bowel diseases.

Authors:  Justyna Kikut; Nina Konecka; Maciej Ziętek; Danuta Kulpa; Małgorzata Szczuko
Journal:  Eur J Nutr       Date:  2021-03-31       Impact factor: 5.614

2.  Increased NOX1 and DUOX2 expression in the colonic mucosa of patients with chronic functional constipation.

Authors:  Xiuqin Wei; Mei Xue; Chunbo Kang; Lei Gao; Mengqiao Zhang; Chao Ma; Wei Jia; Yufeng Zheng; Lei Cao; Pan Chen; Shujing Jiang; Fong-Fong Chu; Qiang Gao
Journal:  Medicine (Baltimore)       Date:  2022-08-12       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.